Early and Efficient Detection of Mycobacterium tuberculosis in Sputum by Microscopic Observation of Broth Cultures

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kidenya, Benson R ^a,b   Kabangila, Rodrick ^a,b   Peck, Robert N ^a,b   Mshana, Stephen E ^a   Webster, Lauren E ^b   Koenig, Serena P ^c   Johnson, Warren D ^b   Fitzgerald, Daniel W ^b  

^a CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURE TECHNIQUE; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIQUID CULTURE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RELIABILITY; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS;

EID: 84874573540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057527     Document Type: Article

References (39)

1. World Health Organization/Stop TB partnership (2010) 2010/2011 Tuberculosis global facts. World Health Organization, Geneva, Switzerland. Available: http://www.who.int/tb/publications/2010/factsheet_tb_2010_rev21feb11.pdf. Accessed 2011 July 14.
2. Ndung'u PW, Kariuki S, Ng'ang'a Z, Revathi G, (2012) Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi. J Infect Dev Ctries 6: 33-39.
3. Ploubidis GB, Palmer MJ, Blackmore C, Lim TA, Manissero D, et al. (2012) Social determinants of tuberculosis in Europe: A prospective ecological study. Eur Respir J erj01840-2011; published ahead of print, DOI:10.1183/09031936.00184011. Available: http://hinari-gw.who.int/whalecomerj.ersjournals.com/whalecom0/content/early/2012/01/19/09031936.00184011.full.pdfhtml?sid=f4cb68df-c9b8-459a-b09b-bdb4e45b8507. Accessed: 2012 March 14.
4. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, et al. (2008) Treating multidrug-resistant tuberculosis in Tomsk, Russia: Developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci 1136: 1-11.
5. Farmer PE, Nizeye B, Stulac S, Keshavjee S, (2006) Structural violence and clinical medicine. PLoS Med 3: e449 DOI:10.1371/journal.pmed.0030449 Available:http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030449. Accessed 2012 March 14.
6. Davies PD, (2003) The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis. Ann Med 35: 235-243.
7. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, et al. (2006) Microscopic observation drug susceptibility assay for the diagnosis of TB. N Engl J Med 355: 1539-1550.
8. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, et al. (2007) Evaluation of microscopic observation drug susceptibility assay for the detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 45: 1093-1097.
9. Lazarus RP, Kalaiselvan S, John KR, Michael JS, (2012) Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis. Indian J Med Microbiol 30: 64-68.
10. Brady M, Coronel J, Gilman R, Moore D (2008) The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis. Journal of visualized experiments, 11(17), 2-5.
11. Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, et al. (2000) Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 38: 1203-1208.
12. Minion J, Leung E, Menzies D, Pai M, (2010) Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 10(10): 688-98 doi:10.1016/S1473-3099(10)70165-1.
13. Leung E, Minion J, Benedetti A, Pai M, Menzies D (2012) Microcolony culture techniques for tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis: 10.5588/ijtld.10.0065.
14. Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 42: 4432-4437.
15. Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, et al. (2008) Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis 12: 332-337.
16. Michael JS, Daley P, Kalaiselvan S, Latha A, Vijayakumar J, et al. (2010) Diagnostic accuracy of the microscopic observation drug susceptibility assay: A pilot study from India. Int J Tuberc Lung Dis 14: 482-488.
17. Buderer NM, (1996) Statistical methodology: I Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 3: 895-900.
18. Harries AD, Kamenya A, Subramanyam VR, Maher D, Squire SB, et al. (1997) Screening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans R Soc Trop Med Hyg 91(4): 416-419.
19. World Health Organization (2011) Global TB Control Report 2011. World Health Organization, Geneva, Switzerland. Available: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf. Accessed 2012 March 14.
20. American Thoracic Society (1990) Diagnostic standards and classification. Am Rev Respir Dis, 142, 725-735.
21. Burgess AL, Fitzgerald DW, Severe P, Joseph P, Noel E, et al. (2001) Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. AIDS, 15(14), 1875-1879.
22. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, et al. (2000) Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. The Lancet, 356, 1470-1474.
23. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr, (1993) Effects of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342: 268-272.
24. Lyamuya EF, Aboud S, Urassa WK, Sufi J, Mbwana J, et al. (2009) Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infect Dis 9: 19 doi:10.1186/1471-2334-9-19.
25. World Health Organization (1998) Laboratory services in TB control. Parts I, II, and III. Publication no. WHO/tb/98.258. World Health Organization, Geneva, Switzerland.
26. Central TB Division (2009) Revised National TB Control Programme Training Manual for Mycobacterium tuberculosis Culture & Drug susceptibility testing. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare.
27. Cattamanchi A, Davis JL, Worodria W, den Boon S, Yoo S, et al. (2009) Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis. 13: 1130-1136.
28. Davis JL, Huang L, Worodria W, Masur H, Cattamanchi A, et al. (2011) Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: A prospective cohort study. PLoS One 6: e16321 DOI:10.1371/journal.pone.0016321. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029312/?tool=pubmed. Accessed 2012 March 14.
29. Kiraz N, Et L, Akgun Y, Kasifoglu N, Kiremitci A, (2007) Rapid detection of Mycobacterium tuberculosis from sputum specimens using the FASTPlaque TB test. Int J Tuberc Lung Dis 11: 904-908.
30. Park WG, Bishai WR, Chaisson RE, Dorman SE, (2002) Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 40: 4750-4752.
31. Drummond M, Sculpher M, Torrance G (2006) Methods for the economic evaluation of health care programmes, 3rd ed. Journal of Epidemiology & Community Health, 60(9), 823.
32. Koenig SP, Schackman BR, Riviere C, Leger P, Charles M, et al. (2010) Clinical Impact and Cost of Monitoring for Asymptomatic Laboratory Abnormalities among Patients Receiving Antiretroviral Therapy in a Resource-Poor Setting. Clinical Infectious Diseases, 51(5), 600-608.
33. Ardito F, Sanguinetti M, Sechi L, Posteraro B, Masucci L, et al. (2000) Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis. New Microbiol 23(2): 151-158.
34. Chien HP, Yu MC, Wu MH, Lin TP, Luh KT, (2000) Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis 4(9): 866-870.
35. Zhu W, Plikaytis BB, Shinnick TM, (2003) Resuscitation factors from mycobacteria: homologs of Micrococcus luteus proteins. Tuberculosis 83(4): 261-269.
36. Shleeva MO, Bagramyan K, Telkov MV, Mukamolova GV, Young M, et al. (2002) Formation and resuscitation of 'nonculturable' cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase. Microbiology 148, 1581-1591.
37. Mukamolova GV, Turapov O, Malkin J, Woltmann G, Barer MR, (2010) Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum. Am J Respir Crit Care Med 181(2): 174-180.
38. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. New England Journal of Med 363(11): 1005-1015.
39. Cepheid (2012) Cepheid Announces First Phase Of Xpert MTB/RIF Buy-Down For High Burden Developing Countries. Sunnyvale, California, USA. Available: http://ir.cepheid.com/releasedetail.cfm?ReleaseID=698417 Accessed 2013 Jan 11.